Stock Earnings

Question 1

What are Ginkgo Bioworks Holdings Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Ginkgo Bioworks Holdings Inc has a total asset of $1,377, Net loss of $-547

Question 2

What are the key financial ratios for DNA?

Accepted Answer

Ginkgo Bioworks Holdings Inc's Current ratio is 2.08, has a Net margin is -240.96, sales per share of $4.37.

Question 3

How is Ginkgo Bioworks Holdings Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Ginkgo Bioworks Holdings Inc data is not available.

Question 4

Is Ginkgo Bioworks Holdings Inc profitable?

Accepted Answer

no, according to the latest financial statements, Ginkgo Bioworks Holdings Inc has a net loss of $-547

Question 5

Does Ginkgo Bioworks Holdings Inc have any liabilities?

Accepted Answer

yes, Ginkgo Bioworks Holdings Inc has liability of 661

Question 6

How many outstanding shares for Ginkgo Bioworks Holdings Inc?

Accepted Answer

Ginkgo Bioworks Holdings Inc has a total outstanding shares of 54.36

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	230	227	251	477	313	76
Revenue Growth (YoY)	25%	-10%	-47%	52%	312%	41%
Cost of Revenue	48	44	54	204	129	15
Gross Profit	182	182	197	273	184	61
Selling, General & Admin	208	241	192	1,383	863	38
Research & Development	277	424	580	1,052	1,149	159
Operating Expenses	486	665	773	2,436	2,012	198
Other Non Operating Income (Expenses)	13	28	14	132	80	16
Pretax Income	-316	-547	-892	-2,121	-1,838	-124
Income Tax Expense	0	0	0	-15	-1	1
Net Income	-315	-547	-892	-2,104	-1,830	-126
Net Income Growth	-65%	-39%	-57.99%	15%	1,352%	6%
Shares Outstanding (Diluted)	54.85	51.89	48.61	1,679.1	1,359.8	1,874.8
Shares Change (YoY)	7%	7%	-97%	23%	-27%	0%
EPS (Diluted)	-5.74	-10.54	-18.36	-1.25	-1.35	-0.07
EPS Growth	-67%	-43%	1,369%	-7%	1,829%	17%
Free Cash Flow	-274	-382	-336	-304	-310	-193
Free Cash Flow Per Share	-4.99	-7.36	-6.91	-0.18	-0.22	-0.1
Gross Margin	79.13%	80.17%	78.48%	57.23%	58.78%	80.26%
Operating Margin	-132.17%	-212.77%	-229.48%	-453.24%	-584.02%	-180.26%
Profit Margin	-136.95%	-240.96%	-355.37%	-441.09%	-584.66%	-165.78%
Free Cash Flow Margin	-119.13%	-168.28%	-133.86%	-63.73%	-99.04%	-253.94%
EBITDA	-241	-420	-506	-2,120	-1,799	-124
EBITDA Margin	-104.78%	-185.02%	-201.59%	-444.44%	-574.76%	-163.15%
D&A For EBITDA	63	63	70	42	29	13
EBIT	-304	-483	-576	-2,162	-1,828	-137
EBIT Margin	-132.17%	-212.77%	-229.48%	-453.24%	-584.02%	-180.26%
Effective Tax Rate	0%	0%	0%	0.7%	0.05%	-0.8%

Ginkgo Bioworks Holdings Inc (DNA) Price